AI ACELYRIN, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the ACELYRIN, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 23 May 2025 (Disposition). Among the most active insiders: Kim Mina. All data is accessible without an account.
€307,366
15 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate ACELYRIN, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 May 2025
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
● Director · Executives · 21 May 2025
14,675 shares Common Stock SEC:0001962918-25-000056:0
● Director · Executives · 21 May 2025
50,000 shares Common Stock SEC:0001962918-25-000058:0
◆ Chief Executive Officer · Executives · 21 May 2025
89,526 shares Common Stock SEC:0001962918-25-000068:0
● Chief Medical Officer · Executives · 21 May 2025
121,789 shares Common Stock SEC:0001962918-25-000060:0
● Director · Executives · 21 May 2025
2,999 shares Common Stock SEC:0001962918-25-000052:0
● Chief Legal Officer · Executives · 21 May 2025
121,587 shares Common Stock SEC:0001962918-25-000064:0
● Director · Executives · 21 May 2025
15,000 shares Common Stock SEC:0001962918-25-000054:0
● Director · Executives · 21 May 2025
60,000 shares Common Stock SEC:0001962918-25-000062:0
● Director · Executives · 21 May 2025
9,334,735 shares 0Common Stock, par value $0.00001 per share ("Common Stock") SEC:0000902664-25-002533:0
◆ Chief Executive Officer · Executives · 15 May 2025
30,851 shares 0Common Stock SEC:0001962918-25-000038:0
▼ Chief Medical Officer · Executives · 17 Mar 2025
3,211 shares @ US$2.744 100.0% of flow Common Stock SEC:0001962918-25-000026:0
▼ Chief Executive Officer · Executives · 17 Mar 2025
17,986 shares @ US$2.744 26.8% of flow Common Stock SEC:0001962918-25-000031:0
▼ Chief Legal Officer · Executives · 17 Mar 2025
3,913 shares @ US$2.744 100.0% of flow Common Stock SEC:0001962918-25-000029:0
◆ Chief Medical Officer · Executives · 23 Jan 2025
125,000 shares 0Common Stock SEC:0001962918-25-000009:0
◆ Chief Legal Officer · Executives · 23 Jan 2025
125,000 shares 0Common Stock SEC:0001962918-25-000005:0
◆ Chief Executive Officer · Executives · 23 Jan 2025
575,000 shares 0Common Stock SEC:0001962918-25-000007:0
▼ Director · Executives · 17 Jul 2024
1 shares @ US$6.86 0.0% of flow Common Stock SEC:0001962918-24-000099:0
● Chief Operating Officer · Executives · 15 May 2024
10,298 shares @ US$4.47 100.0% of flow Common Stock SEC:0001962918-24-000063:0
● CLO & Head of People · Executives · 15 May 2024
921 shares @ US$4.47 100.0% of flow Common Stock SEC:0001962918-24-000060:0
● Chief Executive Officer · Executives · 15 May 2024
10,230 shares @ US$4.47 24.8% of flow Common Stock SEC:0001962918-24-000061:0
▼ Chief Executive Officer · Executives · 1 Apr 2024
9,961 shares @ US$6.6283 25.2% of flow Common Stock SEC:0001962918-24-000036:0
▼ Chief Executive Officer · Executives · 20 Feb 2024
15,701 shares @ US$7.6048 45.4% of flow Common Stock SEC:0001962918-24-000015:0
▼ Chief Executive Officer · Executives · 2 Jan 2024
10,691 shares @ US$7.407 29.4% of flow Common Stock SEC:0001962918-24-000002:0
● Director · Executives · 4 Oct 2023
14,675 shares 0Common Stock SEC:0001962918-23-000037:0
● Chief Financial Officer · Executives · 4 Oct 2023
40,763 shares 0Common Stock SEC:0001962918-23-000034:0
25 of 43 declarations
Load more (18 remaining) 关于 ACELYRIN, Inc. ACELYRIN, Inc. 是一家在XNAS市场上市的公司，专注于开发严重疾病的创新疗法。